20 deals · $23.9B announced on this page
~$1.4BreportedTake-private·Technology·Oct 12, 2026
Persistent locks up 94% of Nagarro, plans squeeze-out
India's Persistent Systems has secured about 94.04% of German digital engineering firm Nagarro after its voluntary takeover offer closed. Tendered shares totaled about 71.94%, on top of a 22.10% stake bought from Lantano Beteiligungen. That is well above the 50%-plus-one-share threshold. Having passed 90%, Persistent plans to squeeze out remaining minority holders and take Nagarro private.
$5.8BTake-private·Healthcare & Life Sciences·Oct 8, 2026
CD&R and McKesson to take Option Care Health private for $5.8B
Option Care Health agreed to be acquired by private equity firm CD&R and drug distributor McKesson for $32.05 per share in cash. The deal values the home and alternate-site infusion provider at about $5.8 billion. The offer is a roughly 37% premium to Option Care's October 5 closing price.
$2.43/share offerTake-private·Media & Telecom·Oct 8, 2026
Clear Channel Outdoor gets CFIUS nod for Mubadala Capital buyout
Clear Channel Outdoor received CFIUS clearance for its acquisition by Mubadala Capital, satisfying all regulatory requirements. Shareholders will receive $2.43 per share in cash, and the deal is expected to close on or about October 14, 2026, after which the stock will be delisted from the NYSE.
$5.8BTake-private·Healthcare & Life Sciences·Oct 7, 2026
CD&R and McKesson to take Option Care Health private for $5.8B
Clayton, Dubilier & Rice and McKesson agreed to acquire Option Care Health for $32.05 per share in a deal valued at about $5.8 billion. CD&R will hold majority ownership, while McKesson invests roughly $1.4 billion for about 49%, with a framework to potentially buy CD&R's stake later. Option Care shares jumped about 34%.
$5.8BTake-private·Healthcare & Life Sciences·Oct 6, 2026
CD&R and McKesson to take Option Care Health private at $5.8B value
CD&R and McKesson signed a definitive agreement to acquire Option Care Health, an independent provider of home and alternate site infusion services, for $32.05 per share in cash, reflecting a total enterprise value of about $5.8 billion. The Nasdaq-listed company will be taken private through the joint private equity and strategic partnership.
~$375MreportedTake-private·Healthcare & Life Sciences·Completed·Oct 6, 2026
Altaris completes take-private of Simulations Plus
Simulations Plus, the Nasdaq-listed developer of model-informed and AI-accelerated drug development software, announced the completion of its acquisition by affiliates of healthcare-focused investment firm Altaris. The transaction was originally announced on June 16, 2026, and shares of the company were converted at the effective time of the merger.
~$3.7BreportedTake-private·Materials & Chemicals·Completed·Sep 30, 2026
Apollo completes take-private of Nippon Sheet Glass
Apollo-managed funds closed their acquisition of Nippon Sheet Glass, the global architectural, automotive and solar glass maker, and launched a new management structure for the company. Apollo says the deal, done with key financial institutions, will strengthen NSG's balance sheet and fund investment in people and technology. NSG's president called the closing the start of a new chapter for the century-old group.
$114MTake-private·Technology·Sep 30, 2026
Transom Capital to take SoundThinking private at up to $11 a share
Public safety technology company SoundThinking agreed to be acquired by Transom Capital Group via a tender offer of $8.00 per share in cash plus a contingent value right worth up to $3.00 more, for up to $11.00 per share. The upfront price is a 46% premium to the prior close and implies a $114 million enterprise value, rising to about $159 million if the CVR pays out fully. Holders of roughly 33% of shares have agreed to tender.
$5.7BTake-private·Healthcare & Life Sciences·Sep 30, 2026
KKR's $5.7B Integer buyout clears antitrust review early
Integer Holdings said it received early termination of the Hart-Scott-Rodino waiting period for its pending acquisition by an affiliate of KKR-managed funds. The August 2 merger agreement values the medical device CDMO at $127 per share in cash, or roughly $5.7 billion in enterprise value. Shareholders vote at a special meeting on October 21, and the parties still expect to close by the end of 2026 pending other regulatory approvals.
$664MTake-private·Healthcare & Life Sciences·Sep 29, 2026
Webster Equity to take Lifecore Biomedical private in deal worth up to $664M
Lifecore Biomedical agreed to be acquired by Webster Equity Partners in a transaction valued at up to $663.7 million, assuming full achievement of performance milestones. Shareholders receive $6.28 per share in cash at closing plus one non-tradable contingent right. Management framed the deal as funding the CDMO's next growth phase, with multiple customer programs potentially commercializing by the end of 2028.
UndisclosedTake-private·Technology·Sep 24, 2026
Cloopen Shareholders Approve Take-Private Merger with SpringX
Cloopen Group shareholders approved the merger agreement with SpringX Holdings, under which Merger Sub will merge into Cloopen, making it a wholly-owned subsidiary of HoldCo.
27% stake heldTake-private·Consumer & Retail·Terminated·Sep 23, 2026
People Incorporated withdraws bid for MGM Resorts
People Incorporated, which holds about 27% of MGM Resorts, has withdrawn its June 1, 2026 proposal to acquire all public shares, and MGM will continue as a standalone company.
$4.52/ADS offerTake-private·Healthcare & Life Sciences·Rumored·Sep 17, 2026
111 Inc. Gets Going-Private Bid at $4.52 per ADS
111 Inc.'s board received an unsolicited non-binding proposal from its co-founders and Huadeng Tech BioArray Ventures to take the Chinese healthcare platform private at $4.52 per ADS in cash.
$300M benefitsTake-private·Energy & Utilities·Sep 15, 2026
TXNM Energy, Blackstone Infrastructure file revised merger application
TXNM Energy and Blackstone Infrastructure filed a motion with New Mexico regulators to revise their merger application, adding a $300 million customer and community benefits package.
UndisclosedTake-private·Materials & Chemicals·Sep 14, 2026
NNS launches voluntary all-cash offer for all OCI N.V. shares
NNS Holding (Cyprus) is launching a voluntary all-cash public offer for all issued and outstanding shares of Dutch-listed OCI N.V., with the offer period starting 15 September 2026.
UndisclosedTake-private·Technology·Completed·Sep 1, 2026
Iris Powered by Generali Completes Management-Led Buyout from Redion
Identity protection provider Iris completed a management-led buyout from Redion Group and will operate independently under the new brand Iris OnWatch.
UndisclosedTake-private·Business Services·Completed·Sep 1, 2026
TPM Sells ColorLab in Management-Led Buyout
TPM sold ColorLab to longtime vice president Dustin Batson in a management-led acquisition backed by Greenville-based Cowart Awards; terms were not disclosed.
$5.75/shareTake-private·Healthcare & Life Sciences·Completed·Sep 1, 2026
Black Pearl Completes $5.75/Share Tender Offer for Selectis Health
Black Pearl Equities completed its all-cash tender offer at $5.75 per share for Selectis Health, acquiring about 90.93% of shares and will squeeze out the remainder via merger.
$5.75/share offerTake-private·Healthcare & Life Sciences·Aug 28, 2026
Black Pearl Extends $5.75-Per-Share Tender Offer for Selectis Health
Black Pearl Equities extended its all-cash tender offer for all outstanding shares of Selectis Health at $5.75 per share to August 31, 2026.
UndisclosedTake-private·Aerospace & Defense·Completed·Aug 27, 2026
Arcline completes take-private of AstroNova
Arcline Investment Management completed its previously announced take-private acquisition of AstroNova, a provider of aerospace and product identification printing solutions.